Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia or Schizoaffective”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03669640
What this trial is testing

Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms

Who this might be right for
Schizophrenia, Schizoaffective Disorder
Hoffmann-La Roche 131
Post-approval studies (Phase 4)Study completedNCT00501618
What this trial is testing

Equivalence of Generic Clozapine to Orally Dissolving Clozapine in Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 20
Testing effectiveness (Phase 2)Study completedNCT02230384
What this trial is testing

Novel Smoking Cessation Drug for Schizophrenia

Who this might be right for
Smoking Cessation
K.N. Roy Chengappa 62
Early research (Phase 1)Study completedNCT01592110
What this trial is testing

A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Zogenix, Inc. 40
Early research (Phase 1)Study completedNCT02186769
What this trial is testing

An Randomized Open-Label PK Study of LY03004 Compared to Risperdal® Consta® in Stable Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Luye Pharma Group Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT00141479
What this trial is testing

To Evaluate the Impact of Treatment Interruption on Re-initiation of Bifeprunox

Who this might be right for
SchizophreniaSchizoaffective Disorder
Solvay Pharmaceuticals
Post-approval studies (Phase 4)Study completedNCT00090012
What this trial is testing

Comparison of Continuing Olanzapine to Switching to Quetiapine in Overweight or Obese Patients With Schizophrenia and Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Eli Lilly and Company 340
Not applicableEnded earlyNCT06002958
What this trial is testing

Horyzons: Implementation and Integration in Clinical Practice

Who this might be right for
SchizophreniaSchizophreniform DisordersSchizoaffective Disorder+1 more
University of North Carolina, Chapel Hill 52
Not applicableStudy completedNCT00312598
What this trial is testing

Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more
University of North Carolina, Chapel Hill 30
Not applicableStudy completedNCT06007105
What this trial is testing

SUCCEED Africa: Support, Comprehensive Care and Empowerment of People With Psychosocial Disabilities

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizotypal Disorder+8 more
London School of Hygiene and Tropical Medicine 425
Not applicableUnknownNCT00861003
What this trial is testing

An Adherence Study of Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Korea University Guro Hospital 57
Not applicableStudy completedNCT00454883
What this trial is testing

Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.

Who this might be right for
Affective Psychosis, BipolarManiaManic-Depressive Psychosis
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 379
Post-approval studies (Phase 4)Study completedNCT00306475
What this trial is testing

Does The Addition Of Divalproex Sodium ER To An Atypical Antipsychotic Drug (APD) Improve Cognition And Psychopathology In Outpatients With Schizophrenia (SCH) Or Schizoaffective Disorder (SAD)?

Who this might be right for
SchizophreniaSchizoaffective Disorder
Northwestern University 60
Large-scale testing (Phase 3)UnknownNCT04093518
What this trial is testing

Estradiol as add-on to Antipsychotics

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorders
Tangent Data 100
Early research (Phase 1)Study completedNCT01788774
What this trial is testing

Pharmacokinetic, Safety, and Tolerability Study of Risperidone ISM® at Different Dose Strengths

Who this might be right for
SchizophreniaSchizoaffective Disorder
Rovi Pharmaceuticals Laboratories 36
Early research (Phase 1)Study completedNCT01094249
What this trial is testing

A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective Disorder

Who this might be right for
SchizophreniaBipolar DisorderPsychotic Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 9
Post-approval studies (Phase 4)Study completedNCT00649064
What this trial is testing

The Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs

Who this might be right for
Schizoaffective DisorderSchizophrenia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 46
Not applicableStudy completedNCT07043803
What this trial is testing

Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders

Who this might be right for
Schizophenia DisorderSchizoaffective DisorderBipolar Disorder+1 more
University of Pittsburgh 53
Post-approval studies (Phase 4)Study completedNCT00206102
What this trial is testing

The Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
AstraZeneca 1,098
Post-approval studies (Phase 4)Looking for participantsNCT07105111
What this trial is testing

Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+2 more
Neurocrine Biosciences 100
Next Page